Featured Research

from universities, journals, and other organizations

Timing Is Everything When Using IL-7 To Boost Antiviral Immunity

Date:
February 3, 2008
Source:
Journal of Clinical Investigation
Summary:
CD8+ T cells are an important component of the antiviral immune response. Much research effort is being invested in identifying new ways to boost antiviral immune responses in individuals with chronic viral infections. Although the use of the soluble factor IL-7 has proven attractive, new data indicate that the timing of IL-7 treatment is important in determining how effective it is at enhancing antiviral immunity.

CD8+ T cells are an important component of antiviral immune responses.

Related Articles


Much research effort is being invested in identifying new ways to boost antiviral immune responses in individuals with chronic viral infections (such as those infected with HIV and hepatitis C virus) and to boost the efficacy of vaccines designed to target these viruses.

The use of the soluble factor IL-7, which is known to be important in the generation and maintenance of memory CD8+ T cells, has proven attractive. However, new data, generated in mice by M. Suresh and colleagues at the University of Wisconsin--Madison, have indicated that the timing of IL-7 treatment is important in determining how effective it is at enhancing antiviral immunity.

In the study, IL-7 was shown to enhance the number and function of memory CD8+ T cells only if it was administered during the contraction phase of the immune response mounted after mice were infected with either lymphocytic choriomeningitis virus or vaccinia virus, or were administered a DNA vaccine.

Importantly, CD8+ T cells from IL-7--treated mice exhibited improved viral control. These data have clinical implications for the use of IL-7 as an immunotherapeutic agent both to bolster vaccine-induced CD8+ T cell memory and to boost the immune response of individuals with a chronic viral infection.

The article "Effects of IL-7 on memory CD8+ T cell homeostasis are influenced by the timing of therapy in mice" was published in the Journal of Clinical Investigation February 1, 2008.


Story Source:

The above story is based on materials provided by Journal of Clinical Investigation. Note: Materials may be edited for content and length.


Cite This Page:

Journal of Clinical Investigation. "Timing Is Everything When Using IL-7 To Boost Antiviral Immunity." ScienceDaily. ScienceDaily, 3 February 2008. <www.sciencedaily.com/releases/2008/02/080203101434.htm>.
Journal of Clinical Investigation. (2008, February 3). Timing Is Everything When Using IL-7 To Boost Antiviral Immunity. ScienceDaily. Retrieved October 31, 2014 from www.sciencedaily.com/releases/2008/02/080203101434.htm
Journal of Clinical Investigation. "Timing Is Everything When Using IL-7 To Boost Antiviral Immunity." ScienceDaily. www.sciencedaily.com/releases/2008/02/080203101434.htm (accessed October 31, 2014).

Share This



More Health & Medicine News

Friday, October 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Melafind: Spotting Melanoma Without a Biopsy

Melafind: Spotting Melanoma Without a Biopsy

Ivanhoe (Oct. 31, 2014) The MelaFind device is a pain-free way to check suspicious moles for melanoma, without the need for a biopsy. Video provided by Ivanhoe
Powered by NewsLook.com
Battling Multiple Myeloma

Battling Multiple Myeloma

Ivanhoe (Oct. 31, 2014) The answer isn’t always found in new drugs – repurposing an ‘old’ drug that could mean better multiple myeloma treatment, and hope. Video provided by Ivanhoe
Powered by NewsLook.com
Chronic Inflammation and Prostate Cancer

Chronic Inflammation and Prostate Cancer

Ivanhoe (Oct. 31, 2014) New information that is linking chronic inflammation in the prostate and prostate cancer, which may help doctors and patients prevent cancer in the future. Video provided by Ivanhoe
Powered by NewsLook.com
Sickle Cell: Stopping Kids’ Silent Strokes

Sickle Cell: Stopping Kids’ Silent Strokes

Ivanhoe (Oct. 31, 2014) Blood transfusions are proving crucial to young sickle cell patients by helping prevent strokes, even when there is no outward sign of brain injury. Video provided by Ivanhoe
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins